InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: HALF FULL GLASS post# 18632

Saturday, 04/11/2009 1:23:58 AM

Saturday, April 11, 2009 1:23:58 AM

Post# of 30387
"Prostate cancer vs. normal
Stage I 70% 100%
Stage II 76% 100%
Stage III 85% 100%
Stage IV 86% 100%
Prostate cancer vs. BPH (Stages I & II) 75% 90%"

Half, Studies are just studies. I notice you did not comment on the prostate study done in Nov 2004. Let's compare those studies to the one two years later.

How about the studies at the latest ISOBM where Moro varied the cutoff levels?

How about the actual clinical trials where DR70 specificity plunged to 65%? RECAF has never done any clinical trials because Abbott bailed.

It is obvious you think RECAF is the greatest. Why is it almost unknown when it has been around for 25 years? It will never be approved as a screening test and that is where the big money is supposed to be. You also seem to not understand that what is needed is early detection of fast growing cancers, not just early detection. The fact that a larger percentage of men will test positive from slow growing prostate cancer will make the test a waste of time. The body produces cancer cells frequently and some go away on their own and some never cause a problem. I know the medical system is broken and you want to break it even more.

"Interesting science but clinically a waste of time."
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.